£193k
1 period on recordActive16014187Private limited companyStevenage
ISOFORM ONCOLOGY LTD
Significant control: Lee Douglas Larcombe (25–50%), Sarah Louise Morgan (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Isoform Oncology Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Isoform Oncology Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ISOFORM ONCOLOGY LTD is an active private limited company (company number 16014187) incorporated on 12 October 2024, registered in Stevenage. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 October 2025, showing net assets of £193k, with 3 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
Peer position · net assets
By net assets it sits in the top quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- Dr Lee Douglas Larcombe
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Sarah Louise Morgan
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 12 October 20242 yrs ago
- Next accounts due
- 31 July 2027in 276 days
- Confirmation statement due
- 26 October 2027in 363 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
3
1 period on record| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | £193k | — | — | £0 | — | — | 3 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £192,964 at 31 October 2025
- Incorporated two to five years agoIncorporated 12 October 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 363 days
- Next accounts duein 276 days
- Accounts period endNet assets £193k · micro accounts
- Incorporated
08
Similar companies in Hertfordshire
- AWRIDIAN CONSULTING LTDWare · inc. Oct 2024
- LYME-BITE LIMITEDHitchin · inc. Sept 2024
- MYCO BIOTEC LTDHertford · inc. Sept 2024
- MSB BIOMOTION CONSULTING LIMITEDSt. Albans · inc. Jun 2024
- BIOFORGEUK LTDRoyston · inc. Feb 2025
- BIORES LTDStevenage · inc. Mar 2025
All companies incorporated on 12 October 2024 · in Oct 2024.
09
Reminders for ISOFORM ONCOLOGY LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.